{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:11:54Z","timestamp":1789150314035,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T00:00:00Z","timestamp":1653091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T00:00:00Z","timestamp":1653091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1038\/s41443-022-00583-3","type":"journal-article","created":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T05:02:34Z","timestamp":1653109354000},"page":"50-54","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Medications mostly associated with priapism events: assessment\n            of the 2015\u20132020 Food and Drug Administration (FDA) pharmacovigilance database\n            entries"],"prefix":"10.1038","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4828-4316","authenticated-orcid":false,"given":"Nicol\u00f2","family":"Schifano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2347-9504","authenticated-orcid":false,"given":"Paolo","family":"Capogrosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0040-784X","authenticated-orcid":false,"given":"Luca","family":"Boeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Fallara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer Onur","family":"Cakir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8046-1963","authenticated-orcid":false,"given":"Fabio","family":"Castiglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussain M.","family":"Alnajjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asif","family":"Muneer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Deho\u2019","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Schifano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Montorsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0595-7165","authenticated-orcid":false,"given":"Andrea","family":"Salonia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,21]]},"reference":[{"key":"583_CR1","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.eururo.2013.11.008","volume":"65","author":"A Salonia","year":"2014","unstructured":"Salonia A, Eardley I, Giuliano F, Hatzichristou D, Moncada I, Vardi\n                    Y, et al. European association of urology guidelines on priapism. Eur Urol.\n                    2014;65:480\u20139. https:\/\/doi.org\/10.1016\/j.eururo.2013.11.008","journal-title":"Eur Urol"},{"key":"583_CR2","doi-asserted-by":"crossref","unstructured":"Salonia A, Bettocchi C, Boeri L, Capogrosso P, Carvalho J, Cilesiz\n                    NC, et al. EAU Working Group on Male Sexual and Reproductive Health. European\n                    Association of Urology Guidelines on Sexual and Reproductive Health-2021 Update:\n                    Male Sexual Dysfunction. Eur Urol. 2021;80:333\u201357.","DOI":"10.1016\/j.eururo.2021.06.007"},{"key":"583_CR3","doi-asserted-by":"publisher","first-page":"e2020010","DOI":"10.23750\/abm.v91i10-S.10233","volume":"91","author":"A Arrichiello","year":"2020","unstructured":"Arrichiello A, Angileri SA, Buccimazza G, Di Bartolomeo F, Di\n                    Meglio L, Liguori A, et al. Interventional radiology management of high flow\n                    priapism: review of the literature. Acta Biomed. 2020;91:e2020010 https:\/\/doi.org\/10.23750\/abm.v91i10-S.10233","journal-title":"Acta Biomed"},{"key":"583_CR4","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/bju.12686","volume":"114","author":"E Zacharakis","year":"2014","unstructured":"Zacharakis E, Garaffa G, Raheem AA, Christopher AN, Muneer A, Ralph\n                    DJ. Penile prosthesis insertion in patients with refractory ischaemic priapism:\n                    early vs delayed implantation. BJU Int. 2014;114:576\u201381. https:\/\/doi.org\/10.1111\/bju.12686","journal-title":"BJU Int"},{"key":"583_CR5","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/S0090-4295(01)00941-4","volume":"57","author":"IA Eland","year":"2001","unstructured":"Eland IA, Van der Lei J, Stricker BHC, Sturkenboom MJCM. Incidence\n                    of priapism in the general population. Urology. 2001;57:970\u20132. https:\/\/doi.org\/10.1016\/S0090-4295(01)00941-4","journal-title":"Urology"},{"key":"583_CR6","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.sxmr.2020.10.003","volume":"9","author":"T Hwang","year":"2021","unstructured":"Hwang T, Shah T, Sadeghi-Nejad H. A review of antipsychotics and\n                    priapism. Sex Med Rev. 2021;9:464\u201371. https:\/\/doi.org\/10.1016\/j.sxmr.2020.10.003","journal-title":"Sex Med Rev"},{"key":"583_CR7","first-page":"1543","volume":"322","author":"R Rubin","year":"2019","unstructured":"Rubin R. Use of illicit drugs continues to rise. JAMA.\n                    2019;322:1543 https:\/\/jamanetwork.com\/journals\/jama\/article-abstract\/2753347 accessed 18 Aug 2021","journal-title":"JAMA"},{"key":"583_CR8","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.jsxm.2019.07.024","volume":"16","author":"H Zhao","year":"2019","unstructured":"Zhao H, Berdahl C, Bresee C, Moradzadeh A, Houman J, Kim H, et al.\n                    Priapism from recreational intracavernosal injections in a high-risk\n                    metropolitan community. J Sex Med. 2019;16:1650\u20134. https:\/\/doi.org\/10.1016\/j.jsxm.2019.07.024","journal-title":"J Sex Med"},{"key":"583_CR9","doi-asserted-by":"publisher","unstructured":"Montastruc JL, Sommet A, Bagheri H, Lapeyre-Mestre M. Benefits and\n                    strengths of the disproportionality analysis for identification of adverse drug\n                    reactions in a pharmacovigilance database. Br J Clin Pharmacol. 2011. https:\/\/doi.org\/10.1111\/j.1365-2125.2011.04037.x.","DOI":"10.1111\/j.1365-2125.2011.04037.x"},{"key":"583_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1177\/0018578718795271","volume":"54","author":"A Kumar","year":"2019","unstructured":"Kumar A. The newly available FAERS public dashboard: implications\n                    for health care professionals. Hosp Pharm. 2019;54:75\u20137. https:\/\/doi.org\/10.1177\/0018578718795271","journal-title":"Hosp Pharm"},{"key":"583_CR11","unstructured":"EMA. Guideline on good pharmacovigilance practices (GVP) Annex\n                    I\u2014Definitions (Rev 4). Heads Med Agencies. 2017."},{"key":"583_CR12","doi-asserted-by":"crossref","unstructured":"Schifano N, Chiappini S, Castiglione F, Salonia A, Schifano F. Is\n                    medicinal ketamine associated with urinary dysfunction issues? Assessment of\n                    both the European Medicines Agency (EMA) and the UK Yellow Card Scheme\n                    pharmacovigilance database-related reports. Low Urin Tract Symptoms.\n                    2020.","DOI":"10.1111\/luts.12355"},{"key":"583_CR13","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s40263-016-0359-y","volume":"30","author":"S Chiappini","year":"2016","unstructured":"Chiappini S, Schifano F. A decade of gabapentinoid misuse: an\n                    analysis of the European Medicines Agency\u2019s \u2018suspected adverse drug reactions\u2019\n                    database. CNS Drugs. 2016;30:647\u201354. https:\/\/doi.org\/10.1007\/s40263-016-0359-y","journal-title":"CNS Drugs"},{"key":"583_CR14","unstructured":"European Medicines Agency. Guideline on the use of statistical\n                    signal detection methods in the EudraVigilance data analysis system.\n                    2008."},{"key":"583_CR15","unstructured":"WHO. The WHO Programme for International Drug Monitoring.\n                    2015."},{"key":"583_CR16","doi-asserted-by":"publisher","unstructured":"Felicetti P, Trotta F, Bonetto C, Santuccio C, Brauchli Pernus Y,\n                    Burgner D, et al. Spontaneous reports of vasculitis as an adverse event\n                    following immunization: a descriptive analysis across three international\n                    databases. Vaccine. 2016. https:\/\/doi.org\/10.1016\/j.vaccine.2015.09.027.","DOI":"10.1016\/j.vaccine.2015.09.027"},{"key":"583_CR17","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.sxmr.2018.09.002","volume":"7","author":"ND Scherzer","year":"2019","unstructured":"Scherzer ND, Reddy AG, Le TV, Chernobylsky D, Hellstrom WJG.\n                    Unintended consequences: a review of pharmacologically-induced priapism. Sex Med\n                    Rev. 2019;7:283\u201392. https:\/\/doi.org\/10.1016\/j.sxmr.2018.09.002","journal-title":"Sex Med Rev"},{"key":"583_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-014-1658-1","author":"B Grundmark","year":"2014","unstructured":"Grundmark B, Holmberg L, Garmo H, Zethelius B. Reducing the noise\n                    in signal detection of adverse drug reactions by standardizing the background: a\n                    pilot study on analyses of proportional reporting ratios-by-therapeutic area.\n                    Eur J Clin Pharm. 2014. https:\/\/doi.org\/10.1007\/s00228-014-1658-1","journal-title":"Eur J Clin Pharm"},{"key":"583_CR19","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jsxm.2020.11.017","volume":"18","author":"R Dutta","year":"2021","unstructured":"Dutta R, Matz EL, Overholt TL, Anderson WB, Deebel NA, Cowper M, et\n                    al. Patient education is associated with reduced delay to presentation for\n                    management of ischemic priapism: a retrospective review of 123 men. J Sex Med.\n                    2021;18:385\u201390. https:\/\/doi.org\/10.1016\/j.jsxm.2020.11.017","journal-title":"J Sex Med"},{"key":"583_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4111\/icu.20200195","volume":"62","author":"T Shah","year":"2021","unstructured":"Shah T, Deolanker J, Luu T, Sadeghi-Nejad H. Pretreatment screening\n                    and counseling on prolonged erections for patients prescribed trazodone.\n                    Investig Clin Urol. 2021;62:85\u20139. https:\/\/doi.org\/10.4111\/icu.20200195","journal-title":"Investig Clin Urol"},{"key":"583_CR21","doi-asserted-by":"publisher","unstructured":"Matz A, Ambinder D, Spencer E, Phillips J, Wong NC. Review of\n                    priapism litigation in the United States. Urology. 2021. https:\/\/doi.org\/10.1016\/j.urology.2021.05.001.","DOI":"10.1016\/j.urology.2021.05.001"},{"key":"583_CR22","unstructured":"Panchatsharam PK, Durland J, Zito PM. Physiology, erection. physiol\n                    erection [Updated 9 May 2021] 2021: In: StatPearls [Internet]. Treasure Island\n                    (FL). https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK513278\/ (accessed 18 Aug 2021)."},{"key":"583_CR23","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1038\/sj.ijir.3900506","volume":"12","author":"A Traish","year":"2000","unstructured":"Traish A, Kim NN, Moreland RB, Goldstein I. Role of alpha\n                    adrenergic receptors in erectile function. Int J Impot Res.\n                    2000;12:S48\u201363. https:\/\/doi.org\/10.1038\/sj.ijir.3900506","journal-title":"Int J Impot Res"},{"key":"583_CR24","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1080\/15622975.2018.1520396","volume":"20","author":"T Greiner","year":"2019","unstructured":"Greiner T, Schneider M, Regente J, Toto S, Bleich S, Grohmann R, et\n                    al. Priapism induced by various psychotropics: a case series. World J Biol\n                    Psychiatry. 2019;20:505\u201312. https:\/\/doi.org\/10.1080\/15622975.2018.1520396","journal-title":"World J Biol Psychiatry"},{"key":"583_CR25","doi-asserted-by":"crossref","unstructured":"Dent LA, Brown WC, Murney JD. Citalopram-induced priapism.\n                    Pharmacotherapy. 2002;22:538\u201341.","DOI":"10.1592\/phco.22.7.538.33672"},{"key":"583_CR26","unstructured":"Trivedi SK, Mangot AG, Sinha S. Aripiprazole-induced priapism\n                    n.d."},{"key":"583_CR27","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1097\/SMJ.0b013e3181c04775","volume":"102","author":"S Koirala","year":"2009","unstructured":"Koirala S, Penagaluri P, Smith C, Lippmann S. Priapism and\n                    risperidone. South Med J. 2009;102:1266\u20138. https:\/\/doi.org\/10.1097\/SMJ.0b013e3181c04775","journal-title":"South Med J"},{"key":"583_CR28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1136\/bmj.312.7022.44","volume":"312","author":"D Goldmeier","year":"2002","unstructured":"Goldmeier D. Prolonged erections produced by dihydrocodeine and\n                    sildenafil. BMJ. 2002;312:44 https:\/\/doi.org\/10.1136\/bmj.312.7022.44","journal-title":"BMJ"},{"key":"583_CR29","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2209\/tdcpublication.40.215","volume":"40","author":"T Aoyagi","year":"1999","unstructured":"Aoyagi T, Hayakawa K, Miyaji K, Ishikawa H, Hata M. Sildenafil\n                    induced priapism. Bull Tokyo Dent Coll. 1999;40:215\u20137. https:\/\/doi.org\/10.2209\/tdcpublication.40.215","journal-title":"Bull Tokyo Dent Coll"},{"key":"583_CR30","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/01.pec.0000125660.50937.b5","volume":"20","author":"FL Cantrell","year":"2004","unstructured":"Cantrell FL. Sildenafil citrate ingestion in a pediatric patient.\n                    Pediatr Emerg Care. 2004;20:314\u20135. https:\/\/doi.org\/10.1097\/01.pec.0000125660.50937.b5","journal-title":"Pediatr Emerg Care"},{"key":"583_CR31","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1182\/blood.v95.5.1878","volume":"39","author":"R Kumar","year":"2015","unstructured":"Kumar R, Cantrell FL, Galatti L, Fioravanti A, Salvo F, Polimeni G,\n                    et al. Penile fracture after priapism due to sildenafil ingestion: out of frying\n                    pan into the fire. J Anal Toxicol. 2015;39:314\u20135. https:\/\/doi.org\/10.1182\/blood.v95.5.1878","journal-title":"J Anal Toxicol"},{"key":"583_CR32","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1345\/aph.1E383","volume":"39","author":"L Galatti","year":"2005","unstructured":"Galatti L, Fioravanti A, Salvo F, Polimeni G, Giustini SE.\n                    Interaction between tadalafil and itraconazole [4]. Ann Pharmacother.\n                    2005;39:200 https:\/\/doi.org\/10.1345\/aph.1E383","journal-title":"Ann Pharmacother"},{"key":"583_CR33","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1182\/blood.v95.5.1878","volume":"95","author":"AA Kassim","year":"2000","unstructured":"Kassim AA, Fabry ME, Nagel RL. Acute priapism associated with the\n                    use of sildenafil in a patient with sickle cell trait [3]. Blood.\n                    2000;95:1878\u20139. https:\/\/doi.org\/10.1182\/blood.v95.5.1878","journal-title":"Blood"},{"key":"583_CR34","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1093\/jat\/bkv071","volume":"39","author":"V Matheeussen","year":"2015","unstructured":"Matheeussen V, Maudens KE, Anseeuw K, Neels H. A non-fatal\n                    self-poisoning attempt with sildenafil. J Anal Toxicol. 2015;39:572\u20136. https:\/\/doi.org\/10.1093\/jat\/bkv071","journal-title":"J Anal Toxicol"},{"key":"583_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bcr-2018-226562","volume":"2018","author":"D Sharma","year":"2018","unstructured":"Sharma D, Kumar M, Pandey S, Agarwal S. Penile fracture after\n                    priapism due to sildenafil ingestion: out of frying pan into the fire. BMJ Case\n                    Rep. 2018;2018:1\u20132. https:\/\/doi.org\/10.1136\/bcr-2018-226562","journal-title":"BMJ Case Rep"},{"key":"583_CR36","first-page":"515","volume":"109","author":"QS Khan","year":"2016","unstructured":"Khan QS, Tucker P, Lokhande A. Priapism: what cause: mental\n                    illness, psychotropic medications or poly-substance abuse? J Okla State Med\n                    Assoc. 2016;109:515\u20137.","journal-title":"J Okla State Med Assoc"},{"key":"583_CR37","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/j.jsxm.2020.05.019","volume":"17","author":"ME Rezaee","year":"2020","unstructured":"Rezaee ME, Gross MS. Are we overstating the risk of priapism with\n                    oral phosphodiesterase type 5 inhibitors? J Sex Med. 2020;17:1579\u201382. https:\/\/doi.org\/10.1016\/j.jsxm.2020.05.019","journal-title":"J Sex Med"},{"key":"583_CR38","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/clc.4960250310","volume":"25","author":"AL McLeod","year":"2002","unstructured":"McLeod AL, McKenna CJ, Northridge DB. Myocardial infarction\n                    following the combined recreational use of Viagra and cannabis. Clin Cardiol.\n                    2002;25:133\u20134. https:\/\/doi.org\/10.1002\/clc.4960250310","journal-title":"Clin Cardiol"},{"key":"583_CR39","doi-asserted-by":"publisher","first-page":"3736","DOI":"10.1111\/j.1743-6109.2010.01965.x","volume":"7","author":"A Bechara","year":"2010","unstructured":"Bechara A, Casab\u00e9 A, De Bonis W, Helien A, Bertolino MV.\n                    Recreational use of phosphodiesterase type 5 inhibitors by healthy young men. J\n                    Sex Med. 2010;7:3736\u201342. https:\/\/doi.org\/10.1111\/j.1743-6109.2010.01965.x","journal-title":"J Sex Med"},{"key":"583_CR40","doi-asserted-by":"publisher","first-page":"186","DOI":"10.5534\/wjmh.2016.34.3.186","volume":"34","author":"EA Gebreyohannes","year":"2016","unstructured":"Gebreyohannes EA, Bhagavathula AS, Gebresillassie BM, Tefera YG,\n                    Belachew SA, Erku DA. Recreational use of phosphodiesterase 5 inhibitors and its\n                    associated factors among undergraduate male students in an Ethiopian University:\n                    a cross-sectional study. World J Mens Health. 2016;34:186\u201393. https:\/\/doi.org\/10.5534\/wjmh.2016.34.3.186","journal-title":"World J Mens Health"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41443-022-00583-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-022-00583-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-022-00583-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T12:43:22Z","timestamp":1758890602000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41443-022-00583-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,21]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["583"],"URL":"https:\/\/doi.org\/10.1038\/s41443-022-00583-3","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,21]]},"assertion":[{"value":"24 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}